| # | Drug | Count |
|---|---|---|
| 0 | TEPROTUMUMAB | 21 |
| 1 | METHIMAZOLE | 10 |
| 2 | CARVEDILOL | 6 |
| 3 | LEVOTHYROXINE SODIUM | 6 |
| 4 | FUROSEMIDE | 5 |
| 5 | CARBOPLATIN | 4 |
| 6 | LISINOPRIL | 4 |
| 7 | PEMBROLIZUMAB | 4 |
| 8 | ACITRETIN | 3 |
| 9 | ALPRAZOLAM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEPROTUMUMAB | 21 | 0.0035 |
| 1 | CALCIUM ANTACID | 1 | 0.0023 |
| 2 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| 3 | METHIMAZOLE | 10 | 0.0013 |
| 4 | PROPYLTHIOURACIL | 2 | 0.0010 |
| 5 | ACITRETIN | 3 | 0.0006 |
| 6 | SELENIUM | 2 | 0.0005 |
| 7 | DANAZOL | 1 | 0.0004 |
| 8 | FLUOROMETHOLONE | 1 | 0.0003 |
| 9 | NALOXEGOL OXALATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 10 |
| 1 | beta-Adrenergic Blocker [EPC] | 7 |
| 2 | Retinoid [EPC] | 6 |
| 3 | alpha-Adrenergic Blocker [EPC] | 6 |
| 4 | Corticosteroid [EPC] | 5 |
| 5 | Loop Diuretic [EPC] | 5 |
| 6 | Insulin Analog [EPC] | 4 |
| 7 | Platinum-based Drug [EPC] | 4 |
| 8 | Benzodiazepine [EPC] | 3 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 10 | 0.0010 |
| 1 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 2 | Thiazide-like Diuretic [EPC] | 3 | 0.0001 |
| 3 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | alpha-Adrenergic Blocker [EPC] | 6 | 0.0000 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 8 | Retinoid [EPC] | 6 | 0.0000 |
| 9 | beta-Adrenergic Blocker [EPC] | 7 | 0.0000 |